ABSTRACT Transcription enhancer factors 1 (TEF-1 or TEAD) make a highly conserved family of eukaryotic DNA binding proteins that activate not only viral regulatory elements but muscle specific genes and are involved in several developmental processes. In this study, we report the identification and the expression pattern of NTEF-1 (TEAD1) and DTEF-1 (TEAD3), two members of this family in Xenopus laevis. Both X. laevis NTEF-1 (XNTEF-1 or XTEAD1) and DTEF-1 (XDTEF-1 or XTEAD3) possess a 72 amino acid TEA domain characteristic of TEF-1 proteins. XNTEF-1 is a 426 amino acid protein that has 96% identity with the avian or the mammalian NTEF-1 proteins, while XDTEF-1 is a 433 amino acid protein with 77 to 80% identity with the avian and mammalian DTEF-1 sequences respectively. Temporal expression analysis by RT-PCR indicated that the two genes are expressed maternally and throughout embryonic development. In the adult, the two genes are broadly expressed although they showed differences of expression between tissues. Spatial expression analysis by whole mount in situ hybridization showed that the XNTEF-1 and XDTEF-1 mRNAs were predominantly detected in eye, embryonic brain, somites and heart. In animal cap assay, the two genes are activated by bFGF but are differently regulated by BMP4 and the muscle regulatory factor Mef2d.
al., 1997). For instance, homozygous null mice for NTEF-1 die from cardiac insufficiency suggesting that TEF-1 is required for late events in cardiogenesis (Chen et al., 1994) . TEF-1 protein was found to be able to bind the MCAT sequence that has been implicated in the cell-specific regulation of many muscle genes (Farrance et al., 1992; Larkin and Ordahl, 1999) . For instance, we recently showed that the Xenopus laevis α-tropomyosin gene was regulated, in the three muscle lineages, by an MCAT sequence that is essential for the correct temporal and spatial expression of the gene (Pasquet et al., 2006) . TEF-1 protein also regulates non muscle genes like the human somatomammotropin gene whose expression is controlled by DTEF-1 which is strongly expressed in placenta Jiang and Eberhardt, 1997) .
TEF-1 orthologs of other eukaryotes have been shown to regulate distinct developmental processes. In Drosophila melanogaster, the unique TEF-1 ortholog gene, namely scalloped, is involved in wing development as well as neural development (Campbell et al., 1991; Campbell et al., 1992) . In Caenorhabditis elegans, the TEF-1 ortholog egl-44, regulates differentiation of touch-sensitive cells and egg-laying motor neurons (Desai and Horvitz, 1989; Wu et al., 2001) .
The function of TEF-1 genes in vertebrate development might be difficult to explore due to the presence of four genes and their potential redundancy. The amphibian Xenopus laevis can be a suitable model organism to investigate the function of the different TEF-1 genes during early development. Indeed, this model allows gain-of-function studies by mRNA over-expression and loss-of-function studies due to the availability of antisense morpholinos oligos that permit inhibition function of a specific gene or even all members of a gene family (Heasman et al., 2000; Reversade et al., 2005) . In the present study, we report the identification and the expression pattern of NTEF-1 and DTEF-1, two members of the TEF-1 family, in Xenopus laevis.
Results and Discussion
We performed blast searches in databases to identify Xenopus laevis orthologs of mammalian TEF-1 proteins. We identified an expressed sequence tag (EST) (GenBank Accession No. BI444402, IMAGE clone 4434995) which encodes an open reading frame containing a TEA motif. The complete sequence of the retrieved cDNA clone was determined on both strands and registered with the GenBank (Accession No. EF422418). This cDNA encodes a 426 amino acid protein containing a 72 amino acid sequence identical to the TEA DNA binding domain of the avian and mammalian TEF-1 genes. Moreover, this protein shows 96% identity with the chick, human and mouse NTEF-1 proteins but only 67%, 76% and 72% identity with the mammalian ETEF-1, RTEF-1 or DTEF-1 proteins respectively (Fig. 1) . We concluded that this clone codes for the Xenopus laevis NTEF-1 protein and named it XNTEF-1. This XNTEF-1 clone corresponds to the alternative isoform TEF-1α or TEF-1 zeta described by Jiang et al. (2000) and Zuzarte et al. (2000) respectively. We also found in database a partial cDNA sequence, previously released with the Accession No. BG354634 and described in an expression cloning strategy, that corresponded to the XNTEF-1 sequence (Grammer et al., 2000) . One striking feature of the Xenopus NTEF-1 sequence is that its initiates translation with a methionine codon while mammalian and chicken orthologs use an isoleucine codon.
In a search for other Xenopus laevis TEF-1 related sequences we identified an expressed sequence tag (GenBank Accession No. BM180109, IMAGE clone 4959564) whose predicted amino acid sequence contained a 72 amino acid TEA domain. However, this sequence has only 76% identity at the nucleotide level with the XNTEF-1 sequence and thus indicates that it corresponds to a second Xenopus TEF-1 gene. We sequenced the retrieved clone and found that it encodes a 433 amino acid protein showing 70-72% identity with the chick, human and mouse DTEF-1 proteins. When allowing for conservative changes, the homology between the amphibian sequence and avian or mammalian DTEF-1 sequences raises up to 82-84% (Fig. 2) . When compared to the mammalian ETEF-1 and RTEF-1 proteins, the Xenopus protein shows 68% of identity. Moreover, the N-terminal region of the Xenopus protein that precedes the TEA domain has 10-13, 9 and 4 amino acids identical with the DTEF-1, RTEF-1 and ETEF-1 vertebrate sequences respectively. In addition, ETEF-1 has an extra 10 amino acids stretch that is absent from other TEF-1 proteins (Fig. 2) . Therefore, we concluded that this clone represents the Xenopus laevis DTEF-1 and we named it XDTEF-1. The complete sequence of XDTEF-1 was found identical to the sequence Accession No BC082362, which has been previously released in the databank. In a search for Xenopus tropicalis TEF-1 related proteins in databases, we found a protein that has 98% identity at the amino acid level with the Xenopus laevis XDTEF-1, thus indicating the presence of a highly conserved DTEF-1 gene in Xenopus (Fig. 2) .
The expression of the two TEF-1 genes during early Xenopus embryogenesis was investigated by RT-PCR analysis with RNA isolated from various stages of development (Fig. 3A) . XNTEF-1 and XDTEF-1 mRNAs were detected in unfertilized egg indicating that the corresponding genes are maternally expressed. XNTEF-1 mRNA level is constant during development while XDTEF-1 mRNA level increases between stages 7 and 12 and then remains constant during embryogenesis. This increase in mRNA level corresponds to the zygotic transcription activation that occurs at the mid-blastula transition. The maternal expression of X. laevis NTEF-1 and DTEF-1 genes differs from the situation observed in mouse were NTEF-1 and DTEF-1 genes are not expressed in oocytes at levels detectable by in situ hybridization (Kaneko et al., 1997) . In fact, among the four mammalian TEF-1 genes, only ETEF-1 has been found to be expressed during the first seven days of mouse development (Kaneko et al., 1997) .
The expression of the two X. laevis TEF-1 genes in adult tissues revealed that both genes were detected most prominently and at a similar level in the ovaries, lungs and skeletal muscle (Fig. 3A) . They are also expressed, albeit at a lower level, in the skin but are barely detectable in the liver. In the other tissues analysed the two genes show differences in their expression. XNTEF-1 gene is more expressed in the stomach, brain, heart and testes while XDTEF-1 gene is more expressed in the intestine. The expression pattern of NTEF-1 and DTEF-1 mRNAs in adult tissues is very similar between X. laevis and those reported in mouse and chick with the exception of the DTEF-1 gene, which in the chick, is highly expressed in the heart but barely detectable in the lung (Azakie et al., 1996) . Although RT-PCR analysis has shown the presence of XNTEF-1 and XDTEF-1 mRNAs in stages earlier than stage 17 (see Fig. 3A ), we did not detect any localized expression of both genes before stage 17 embryo by whole mount in situ hybridization (data not shown). In order to confirm these data, we have dissected gastrula stage 10 embryos into animal cap and mesodermal regions and analysed XNTEF-1 and XDTEF-1 mRNAs levels in dissected pieces by RT-PCR (Fig. 3B ). There are no major differences in the expression of XNTEF-1 and XDTEF-1 mRNAs in the different embryonic regions tested confirming the ubiquitous expression of both genes in early stages (Fig. 3B) . In stage 17 embryo, expression of XNTEF-1 is found at the most antero-lateral edge of the neural plate that overlaps the eye field and the olfactory placodes (Fig. 4A) . At stage 23, No. BAA12018), mouse RTEF-1 (mRTEF-1, GenBank Accession No. X94441) and mouse DTEF-1 (mDTEF-1, GenBank Accession No. AAH21364) sequences. The highly conserved TEA domain is overlined and red boxes indicate conserved amino acid residues. Yellow boxes indicate the amino acid residues that are identical in at least four of the seven sequences. Grey boxes indicate the amino acid residues that are conserved. Numbers refer to the amino acid sequences and gaps have been introduced to maximize similarity. XNTEF-1 expression marks the trunk somites in addition to the eye and the brain, (Fig. 4B) . At stage 27, XNTEF-1 mRNAs are detected in the eye, the brain, the anterior part of the neural tube and in the somites (Fig. 4C) . The expression in the brain marks predominantly the forebrain but the midbrain-hindbrain boundary and the hindbrain are also marked (Fig.4C) . In transverse section at the level of the brain and eye, expression is observed in the ventricular zone of the midbrain and in the eye (Fig. 4E) . At stage 37, XNTEF-1 is widely expressed in the brain and the head mesenchyme and in the branchial arches (Fig. 4D) . The expression in the somites has decreased and there is a widespread expression in the posterior region of the embryo (Fig. 4D) . In an anterior section the expression of XNTEF-1 is detected in the eye and there is a faint labelling of the embryonic heart (Fig. 4F) . In a more posterior transverse section, the expression is observed in the otic vesicle and the hindbrain (Fig. 4G) .
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xlDTEF-1 ----------MDPNGWSEAGSP-AESTDDLGDSMEKSLDNDAEGVWSPDIEQSFHEALAIYPPCGRRKII 59 xtDTEF-1 ----------MDPNGWSEAGSP-AESTGDLGDSMEKSLDNDAEGVWSPDIEQSFQEALAIYPPCGRRKII 59 cDTEF-1 ----------IASNSWNASSSP-GEGREDGQDGMDKSLDNDAEGVWSPDIEQSFQEALAIYPPCGRRKII 59 hDTEF-1 ----------MASNSWNASSSP-GEAREDGPEGLDKGLDNDAEGVWSPDIEQSFQEALAIYPPCGRRKII
The expression of XDTEF-1 is detected at stage 17 in the midbrain region of the neural plate (Fig. 4H) . XDTEF-1 is also weakly expressed in the paraxial mesoderm. At stage 27, expression is observed in the presomitic mesoderm and the posterior somites (Fig. 4I) . The eye and the midbrain and hindbrain regions are also stained but there is no detectable expression in the 
.). (B)
RT-PCR analysis of total RNA from explants dissected from gastrula stage embryos. Explants are from dorsal-mesoderm (DM), ventral-mesoderm (VM), lateral mesoderm (LM) and animal cap (AC). Total RNA from stage 10 embryo is analysed in control (Emb). Xbra is used as control of pan-mesodermal marker, Xchordin as dorsal mesoderm marker and Xwnt8 as ventro lateral mesoderm. (C) RT-PCR analysis of total RNA from dissected embryonic heart, brain and gut. The stage of the dissected embryos is indicated. Embryo (Emb) RNA is used in control in B and C. ODC in A (Embryo), in B and in C or Rpl8 in A (Adult) were used as loading controls and genomic DNA contamination was assayed by reaction without RT (-RT).
of embryonic heart ( Fig. 4F and 4M ). To assess this finding more definitely, we have dissected heart regions of stage 36 and 42 embryo and performed RT-PCR analysis. As shown in Fig. 3C , XNTEF-1 and XDTEF-1 mRNAs are detected in embryonic cardiac cells like the cardiac specific XMLC2 mRNAs. XNTEF-1 and XDTEF-1 are also expressed in embryonic brain and gut.
Patterning the early Xenopus embryo relies on limited signalling pathways that influence cell fate and ultimately regulate the expression of transcription factors in a cell type dependent manner (Heasman, 2006) . Of major importance are the FGF, activin and BMP signalling pathways. We have tested in the animal cap assay whether these pathways could modulate the expression of the TEF-1 genes. As shown in Fig. 5A , the expression of XNTEF-1 and XDTEF-1 genes is increased at high dose of bFGF (100ng/ ml). While XNTEF-1 gene expression increases between 50 and 100ng/ml of bFGF, the expression of XDTEF-1 starts to increase at 12.5ng/ml of bFGF and follows the increased expression of Xmsr gene that serves as a control of the induction by bFGF. The expression of the two genes are not significantly modified in activin treated explants, even when a high dose of the factor is used (Fig. 5B, lanes 2-4) . BMP4 has no effect on XDTEF-1 gene expression but it reduces, at both concentration tested, the anterior region of the brain (Fig. 4I) . At stage 33, XDTEF-1 expression persists in the midbrain and hindbrain, the eye and the posterior somites, and appears in the branchial arches, the otic vesicle and the anterior region of the brain (Fig. 4J) . In transverse section, the expression is detected in the hindbrain, the otic vesicle and the branchial arches (Fig. 4L) . At stage 37, XDTEF-1 is expressed in head mesenchyme, branchial arches, in brain and in otic vesicle. Its expression also uniformly marks the trunk and posterior regions of the embryo (Fig. 4K) . A faint labelling is observed in the heart region and this is more noticeable in a transverse section (Fig. 4M) . A transverse section in the posterior trunk region shows expression in the most lateral region of the somites (Fig. 4N) .
In summary, the two X. laevis TEF-1 genes show an identical expression in the eye of the early embryo but have distinct expression in the somites with XNTEF-1 being expressed in the trunk somites and XDTEF-1 expression marking the presomitic mesoderm and more posterior somites. The two genes also show distinct expression pattern in the brain. XNTEF-1 is widely expressed in the brain while XDTEF-1 is dynamically expressed with a posterior expression at early stages and then an overall expression at later stages. The expression of NTEF-1 and DTEF-1 in mouse embryo begins between day 7 and day 9. DTEF-1 is specifically expressed in skeletal muscle precursors whereas NTEF-1 is expressed not only in developing skeletal muscle but also in the myocardium (Yasunami et al., 1995; Jacquemin et al., 1996) . In chick, DTEF-1 gene is expressed in the embryonic heart, lung and gizzard (Azakie et al., 1996; Azakie et al., 2005) . We have found a weak expression of XNTEF-1 and XDTEF-1 genes in the early stages
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A expression of XNTEF-1 gene (Fig. 5C , lanes 2 and 3). In those same explants BMP4 induction is controlled by Xαglobin gene expression (Fig. 5C, lanes 2 and 3) . XNTEF-1 and XDTEF-1 genes are both expressed in somites, therefore their expression might be controlled by myogenic factors. Moreover a recent report has suggested that TEF-1 genes could be targets of the myogenic regulatory factor MyoD and the transcription factor Myocyte Enhancer Factor 2 (Mef2) during the differentiation of murine myoblasts (Blais et al., 2005) . We have tested this hypothesis by analysing the expression of XNTEF-1 and XDTEF-1 genes upon overexpression of MyoD and Mef2 mRNAs in animal cap explants. This approach has been widely used for testing the effect of transcription factors on potential genes targets. For example, we have shown that MyoD could activate the α-tropomyosin and the MLC1f/3f skeletal muscle genes and that this activation was increased in the presence of Mef2 (Thézé et al., 1995; Gaillard et al., 1998) . We have tested the effect of MyoD and Mef2a and Mef2d, the two known Xenopus Mef2 proteins. MyoD has no effect on either XNTEF-1 or XDTEF-1 genes expression in such assay (Fig. 5D, lane 2) . On the contrary, Mef2d but not Mef2a induces a significant decrease in the expression of XDTEF-1 gene but not of XNTEF-1 gene (Fig. 5D , lane 3). Mef2a induces a slight but specific increase in the expression of XDTEF-1 gene but has no effect on XNTEF-1 gene expression (Fig. 5D, lane 4) . The co-injection of MyoD with Mef2a or Mef2d does not modify the expression of both TEF-1 genes while it increases, as expected, the expression of XMLC1f gene (Fig.5D, lanes 5, 6) . Together these data show that the two X. laevis TEF-1 genes have distinct spatial expression but are also differently regulated by signalling pathways in the early embryo.
Experimental Procedures
Isolation of Xenopus laevis DTEF-1and NTEF-1 cDNAs
The IMAGE clones #4434995 and # 4959564 were obtained from the MRC Geneservice and the IMAGE Consortium and were fully sequenced on both strands. For sequence comparisons, the following sequences were used: human, Genbank Accession No. P28347 and X94439; mouse, Genbank Accession No. AAA40410, AAH21364, BAA12018 and Xenopus embryo collection and whole mount in situ hybridization Eggs were obtained from Xenopus laevis females primed with human chorionic gonadotrophin, fertilized artificially and cultured in 0.1XMBS (Sive et al., 2000) . Embryos were fixed in MEMFA at the desired stage according to Nieuwkoop and Faber (1994) . Whole-mount in situ hybridization was carried out using current protocol (Sive et al. 2000) with full length anti-sense probes corresponding to XNTEF-1 and XDTEF1 sequences. Embryos were embedded in paraplast, sectioned at 25 nm, dewaxed, dehydrated and embedded in permount.
Microinjection of embryos and animal cap assay
For induction assay, animal cap explants from stage 8-9 embryos were treated with increasing amounts of bFGF (kindly provided by Dr. A. Bikfalvi) or with activin (R&D Systems) and cultured until control embryos reached stage 26 before RT-PCR analysis. For microinjection experiments, the capped mRNAs were synthesized in vitro by using Ambion mMessage mMachine SP6 and T7 kits (Austin, TX) with plasmids generously provided by H. Brivanlou (BMP4) and T. Mohun (MyoD, E12, Mef2a and Mef2d). Embryos were injected in the animal cap with a known amount of the mRNA solution at the two-cell stage into both blastomeres using a Nanoject system (Drummond Scientific). Animal caps were then dissected from stage 8-9 injected embryos and cultured to stage 26 (for BMP4) or stage 12 (for MyoD, Mef2a and Mef2d) before RNA extraction.
RT-PCR
Total RNA from embryos and animal cap explants was isolated with a proteinase K protocol (Sive et al., 2000) . RNA from adult tissues was extracted with trizol solution (Invitrogen) according to manufacturer instructions. 1 µg of total RNA was used in first strand synthesis using Promega MMLV reverse transcriptase following manufacturer instructions. PCR reaction was performed as previously described and a detailed protocol is available upon request (Pasquet et al., 2006) . Reverse transcribed samples without reverse transcriptase were also prepared to check for contamination of genomic DNA. The quantity of input cDNA was verified by similarity of ornithine decarboxylase (ODC) or L8 ribosomal protein gene (Rpl8) signals. Linearity of amplification was confirmed by PCR with consecutive doubling dilutions of input cDNA. The following primer pairs were used:
XNTEF-1
5'-ATTCCAGCCTGCAAACTTCC-3 and 5'-GTGACTAGACACCTGTTTCC-3'; XDTEF-1 5'-TTCTGCGATCGCACTAAGAAGC-3' and 5'-GCCATACATTTTGCCTTC-3'; XMLC1f 5'-TTTGACAAGGAAGGCAATGG-3' and 5'-CATTCTGCTGACAGTTCTTG -3'; XMLC2 5'-GGATGAGATGCTCAAGAGG -3' and 5'-TCTCATCTCCATGCGTGATG-3'; Xwnt8 5'-TGGCAAGAACTTGTCCCAGT-3' and 5'-TTCTGGAATGCCGTCATCTC-3'; Xbra 5'-TTAAGTGCTGTAATCTCTTCA-3' and 5'-CTGGAAGTATGTGAATGGAG-3'; Xchordin 5'-CTCCAATCCAAGACTCCAGC-3' and 5'-GGAGGAGGAGGAGCTTTGGGA-3'; Rpl8 5'-GACGACCAGTACGACGAG-3' and 5'-CACCATGCCTGAAGGCAC-3'; ODC 5'-GTCAATGATGGAGTGTATGGATC-3' and 5'-TCCATTCCGCTCTCCTGACCAC-3'; Xmsr 5'-ACATCATTGTCAGCCTGCAC-3' and 5'-AGTCCCTGTTCTGTAATCAG-3'; Xαglobin 5'-GCTGTCTCACACCATCCAGG-3' and 5'-TGTACTTGGAGGTGAGGACG-3'.
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